Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?